Exchange Announcement • 13 Nov 2024 08:00
Exchange Announcement • 09 Aug 2024 04:32
Exchange Announcement • 13 Jun 2024 04:15
Exchange Announcement • 10 May 2024 04:15
Exchange Announcement • 27 Apr 2024 04:20
ENTITY
MediciNova (MNOV US)
MediciNova (MNOV US)
8
Analysis
Health Care • United States
MediciNova, Inc. operates as a biopharmaceutical company. The Company acquires and develops small molecule therapeutics for the treatment of asthma and COPD, progressive multiple sclerosis, neuropathic pain, methamphetamine addiction, interstitial cystitis, and solid tumor cancers. MediciNova offers its products to the healthcare industry with a focus on the Unites States market.
more
x